Pinned straw:
Some decent momentum overnight on Anteris’ NASDAQ ticker (which is about 90% of the company’s valuation these days) on nothing specific that I can see. Also about twice the average volume. I expect ASX will follow on open which may see a 52 week high today here as well.
There is probably also some revised US price targets to come in the coming weeks as medtech analysts crunch their numbers.
It continues:
No announcements, other than first US patients treated in the Paradigm trial. Possibly the catalyst is Boston Scientific investing in a (probably interior) competitor at a much higher valuation
Up 32% in the last 5 days:
Wall St Mechtech analysts have updated their price targets. Provides a bit of context to last week’s volume and price moves. Things continuing to track well, prices in USD.
